Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early-Stage Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00784888
What this trial is testing

Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy

Who this might be right for
Breast Neoplasms
Pfizer 344
Large-scale testing (Phase 3)Not Yet RecruitingNCT07153757
What this trial is testing

De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Fudan University 2,934
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07492394
What this trial is testing

Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer

Who this might be right for
Breast Cancer
Hebei Medical University Fourth Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02273973
What this trial is testing

Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)

Who this might be right for
Breast Cancer
Genentech, Inc. 334
Testing effectiveness (Phase 2)UnknownNCT03145961
What this trial is testing

A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Institute of Cancer Research, United Kingdom 208
Not applicableUnknownNCT04079270
What this trial is testing

The Breast Cancer Personalized Nutrition Study

Who this might be right for
Breast Cancer
Sheba Medical Center 200
Not applicableStudy completedNCT05445570
What this trial is testing

Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages

Who this might be right for
Colorectal Cancer
Venn Biosciences Corporation 3,002
Not applicableStudy completedNCT06555861
What this trial is testing

Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)

Who this might be right for
Identify FDG PET/CT Parameters Predictive of Local Control
University Hospital, Brest 87
Not applicableUnknownNCT04171986
What this trial is testing

Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis

Who this might be right for
Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 93
Not applicableUnknownNCT03025139
What this trial is testing

Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)

Who this might be right for
Cancer SurvivorEarly-Stage Breast CarcinomaStage 0 Breast Cancer+7 more
Jonsson Comprehensive Cancer Center 96
Testing effectiveness (Phase 2)Study completedNCT01935336
What this trial is testing

Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers

Who this might be right for
Adenocarcinoma of the LungExtensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung Cancer+5 more
University of Colorado, Denver 171
Not applicableWithdrawnNCT04349111
What this trial is testing

An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"

Who this might be right for
Invasive Ductal CarcinomaDuctal Carcinoma In Situ
Xoft, Inc.
Large-scale testing (Phase 3)Study completedNCT00433498
What this trial is testing

Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University College, London 846
Not applicableStudy completedNCT03786198
What this trial is testing

Activity Program During Aromatase Inhibitor Therapy

Who this might be right for
Early Breast Cancer
Swiss Cancer Institute 375
Not applicableStudy completedNCT02521363
What this trial is testing

Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 11
Not applicableUnknownNCT02950337
What this trial is testing

Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Loyola University 41
Not applicableUnknownNCT06351228
What this trial is testing

Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project

Who this might be right for
Cervical Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 400
Not applicableNot Yet RecruitingNCT07491822
What this trial is testing

A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer

Who this might be right for
TNBC
Tianjin Medical University Cancer Institute and Hospital 43
Not applicableNot Yet RecruitingNCT07505095
What this trial is testing

Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice

Who this might be right for
Alzheimer Disease (AD)Alzheimer DementiaMCI-AD, Early Stage Alzheimer's Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine 140
Next Page